Kunzheng Biology

Ningxia Kunzheng Biotechnology Co., Ltd.(referred to as Kunzheng Biotechnlogy) was founded on August 27, 2019, with a registered capital of 125 million yuan. It is a new comprehensive pharmaceutical production enterprise that integrates the production and sales of pharmace - utical intermediates, raw materials and chemical products. The company is located in the south of Ankang Street, east of Suning Avenue, Taiyangshan Development Zone, Wuzhong City, Ningxia Hui Autonomous Region, China, the total area is 300 acres. The company has invested more than 600 million yuan to build an annual production of 3000 tons of L-carnitine and its salts project and an annual production of 5000 tons of fluorobenzene pharmaceutical project, which will be officially put into operation by the end of 2021. After full production, it will become the world's largest producer of L-carnitine projects and one of the largest manufacturers of fluorobenzene pharmaceutical projects in China, the annual output value is over 1.2 billion yuan.